The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,400.00
Bid: 1,397.00
Ask: 1,402.00
Change: -114.00 (-7.53%)
Spread: 5.00 (0.358%)
Open: 1,453.00
High: 1,469.00
Low: 1,365.00
Prev. Close: 1,514.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

17 May 2017 17:36

RNS Number : 4750F
Indivior PLC
17 May 2017
 

Indivior PLC (the 'Company')

Poll results of 3rd Annual General Meeting ('AGM')

May 17, 2017

The Company announces that at its AGM, held on May 17, 2017, all resolutions set out in the Notice of AGM were passed on a poll. 

Resolutions 1 to 17 were passed as Ordinary Resolutions and Resolutions 18 to 21 were passed as Special Resolutions. The following table sets out the votes cast on each resolution: 

RESOLUTION 

VOTES FOR 

% 

VOTES AGAINST 

% 

VOTES TOTAL 

% of ISC VOTED 

VOTES WITHHELD 

1. To receive the Company's accounts, the strategic report and reports of the Directors and the Auditor for the year ended December 31, 2016.

524,593,969

100.00

15,100

0.00

524,609,069

72.76

2,249,385

2. To approve the Directors' Remuneration Report for the year ended December 31, 2016.

491,470,055

93.29

35,357,161

6.71

526,827,216

73.07

38,905

3. To re-appoint Howard Pien as a Director.

494,499,743

94.18

30,581,956

5.82

525,081,699

72.83

1,777,552

4. To re-appoint Shaun Thaxter as a Director.

526,781,490

99.99

32,605

0.01

526,814,095

73.07

45,057

5. To re-appoint Mark Crossley as a Director.

526,793,635

100.00

20,125

0.00

526,813,760

73.07

45,391

6. To re-appoint Yvonne Greenstreet as a Director.

392,217,897

75.47

127,514,829

24.53

519,732,726

72.09

7,126,426

7. To re-appoint A. Thomas McLellan as a Director.

367,951,220

70.80

151,784,716

29.20

519,735,936

72.09

7,123,216

8. To re-appoint Tatjana May as a Director.

526,778,462

99.99

35,744

0.01

526,814,206

73.07

44,946

9. To re-appoint Lorna Parker as a Director.

526,716,359

99.98

101,025

0.02

526,817,384

73.07

41,768

10. To re-appoint Daniel J. Phelan as a Director.

522,856,902

99.25

3,959,688

0.75

526,816,590

73.07

42,562

11. To re-appoint Christian Schade as a Director.

526,439,271

99.93

376,961

0.07

526,816,232

73.07

42,920

12. To re-appoint Daniel Tassé as a Director.

526,785,878

100.00

25,002

0.00

526,810,880

73.07

48,272

13. To re-appoint Lizabeth Zlatkus as a Director.

526,770,965

99.99

43,365

0.01

526,814,330

73.07

44,822

14. To re-appoint PricewaterhouseCoopers LLP as Auditors of the Company.

520,059,460

98.72

6,767,691

1.28

526,827,151

73.07

32,000

15. To authorize the Audit Committee of the Board to determine the remuneration of the Auditors.

524,649,612

99.59

2,201,640

0.42

526,851,252

73.07

7,600

16. To authorize the Company and any of its UK subsidiaries to make political donations and incur political expenditure.

520,738,886

98.85

6,063,612

1.15

526,802,498

73.07

46,645

17. That the Directors be generally and unconditionally authorized to allot shares in the Company up to an aggregate nominal amount of US$48,051,850.

521,220,993

98.94

5,599,906

1.06

526,820,899

73.07

38,253

18. That the Directors be authorized to disapply pre-emption rights up to 5% of the issued capital.

526,674,569

99.97

135,576

0.03

526,810,145

73.07

49,006

19. That the Directors be authorized to disapply pre-emption rights up to an additional 5% for transactions which the Board determines to be an acquisition or other capital investment.

520,497,517

98.80

6,318,185

1.20

526,815,702

73.07

43,448

20. That the Company be generally and unconditionally authorized to make market purchases of its own ordinary shares.

518,740,916

98.77

6,471,697

1.23

525,212,613

72.85

1,646,538

21. That a general meeting other than an annual general meeting may be called on 14 clear days' notice.

511,083,505

97.07

15,449,689

2.93

526,533,194

73.03

324,693

 

At the Annual General Meeting of Indivior PLC held earlier today, votes of 24.53% and 29.20% were recorded against resolutions 6 and 7 to re-appoint Yvonne Greenstreet and A. Thomas McLellan as Directors of the Company. The Board, after discussion, believes it is likely that the level of votes cast against these resolutions was due to the absence of these two directors from certain Board and Committee meetings in 2016.

Tom McLellan did not attend two scheduled Board meetings during the year. One of these absences in May 2016 was as a result of him attending a meeting of cabinet and legislators in the US focused exclusively on opioid issues. Tom McLellan did not attend the Board Meeting in November 2016 as he was attending the US Government's publication of the Surgeon General's Report on Alcohol, Drugs and Health. Both absences were discussed by the Board in advance and it was agreed that it was in the best interests of Indivior, of patients and of wider stakeholders that he attend these meetings.

Tom McLellan is an expert in the field of addiction and at the centre of his work is the health and welfare of patients. He is a very strong contributor on all areas of Board discussion and his expertise is invaluable.

Ad-hoc Board Meetings, by their very nature, are often called at short notice and it is not always possible for Directors to attend, given other scheduled commitments. For this reason, both Tom McLellan and Yvonne Greenstreet were unable to attend a number of such meetings at different times during 2016.

We confirm that Yvonne Greenstreet and Tom McLellan have attended every Board meeting in the current year and have no planned absences.

A copy of the special business resolutions will be submitted to the National Storage Mechanism and will be available to view at http://www.morningstar.co.uk/uk/NSM in due course.

As at the close of business on May 16, 2017, the total number of ordinary shares of US$0.10 each eligible to be voted at the AGM was 720,988,383. Therefore, the total voting rights in the Company as at that time were 720,988,383.

Computershare Investor Services PLC acted as scrutineer of the poll on all resolutions. 

Contact: Kathryn Hudson

Company Secretary

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGQDLFFDEFXBBE
Date   Source Headline
25th Apr 20247:00 amRNS1st Quarter Results
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20243:23 pmRNSHolding(s) in Company
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20242:53 pmRNSNotice of Results
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20249:02 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20242:07 pmRNSPublication of Notice of Annual General Meeting
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20244:00 pmRNSHolding(s) in Company
21st Mar 20242:30 pmRNSAppointment of Independent Non-Executive Director
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20245:14 pmRNSReplacement Director/PDMR Shareholding
18th Mar 20244:21 pmRNSDirector/PDMR Shareholding
18th Mar 20244:17 pmRNSDirector/PDMR Shareholding
18th Mar 20242:00 pmRNSDirector/PDMR Shareholding
18th Mar 202410:45 amRNSHolding(s) in Company
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20244:47 pmRNSDirector/PDMR Shareholding
15th Mar 20244:40 pmRNSDirector/PDMR Shareholding
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20244:06 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20242:00 pmRNSDirector/PDMR Shareholding
13th Mar 20241:09 pmRNSAnnual Financial Report
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20243:33 pmRNSHolding(s) in Company
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.